TriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual Meeting : vimarsana.com

– New data from PERIO-03 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of a TLR9 agonist in pancreatic tumors –

...

Related Keywords

Texas , United States , Trisalu Trinav , Michaels Lee , Stevenc Katz , Twitter , Nasdaq , Trisalus Life Sciences , Exchange Commission , Society Of Immunotherapy , University Of Texas Md Anderson Cancer Center , Linkedin , Pressure Enabled Drug Delivery , Trisalus Infusion System , Medical Oncology , Chief Medical Officer , Pressure Enabled Regional Immuno Oncology , Infusion System , Salus Life Sciences , Pancreatic Retrograde Venous Infusion System , Private Securities Litigation Reform Act , Markets ,